Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Botulinum Toxin A Alone Versus Botulinum Toxin A With Hydrodistension for Treatment of Overactive Bladder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women with refractory overactive bladder symptoms, failing a credible behavioral therapy intervention and medical therapy or not tolerating medical therapy. Patients who are on medical therapy will stop the medical therapy for at least 2 weeks prior to botulinum toxin A treatment in the study~* Female ≥ 18 years old~* Desires further treatment for OAB symptoms.~* Express understanding and ability to perform clean intermittent self-catheterization (CISC) if required.~* Ability to consent~* Ability to complete all study related items and interviews~Exclusion Criteria:~* Post void residual urine volume \> 150 mL as assessed by catheter or ultrasound~* History of intradetrusor botulinum toxin A injection~* History of or current cancer of the genitourinary or gynecology tract~* Neurogenic bladder~* Interstitial cystitis~* Current urinary tract infection (can be treated and re-considered for study)~* Current active sacral neuromodulation device~* Non-English speaking~* History of chronic pelvic pain~* Hematuria not previously evaluated

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Botulinum toxin A alone group (Type: ACTIVE_COMPARATOR): Just the intradetrusor injection of 100 units of botulinum toxin A alone
- Hydrodistention group (Type: EXPERIMENTAL): Hydrodistention at a pressure of 80 cm H2O for 5 minutes, prior to the intradetrusor injection of 100 units of botulinum toxin A

Based on this trial design, predict the completion outcome and termination type (if applicable).